Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF - Study 2

NCT04524026 is registered in ClinicalTrials.gov with Nicholas Macklon as lead sponsor.

NCT NCT04524026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04524026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF - Study 2
Lead sponsor
Nicholas Macklon
Phase
Phase 2
Overall status
Completed
Start date
September 18, 2018
Completion date
November 30, 2020
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ivf